Skip to main content
. 2020 Apr 7;40(4):BSR20193972. doi: 10.1042/BSR20193972

Table 1. Antidiabetic effect of ZnONPs on STZ-induced diabetic mice.

Groups Blood glucose levels (mmol/l)
Dose Fasting glucose levels Glucose levels after 2 h % of inhibition
G-I (Control: Distilled water) 1 ml/mice (oral) 18.68 ± 0.34 18.54 ± 0.16 -
G-II (ZnONPs) 14 mg/kg b.w. (oral) 18.32 ± 0.22 11.04 ± 0.22* 39.74
G-III (ZnONPs + Insulin) 7 mg/kg b.w. (oral) + 0.2 U/50 g (s.c.) 18.62 ± 0.27 11.40 ± 0.21* 38.78
G-IV (Standard: Insulin) 0.4 U/50 g (s.c.) 18.60 ± 0.19 9.56 ± 0.32* 48.60

Mean ± S.E.M. (n=5). Data were analyzed using one-way ANOVA followed by Dunnett’s t test and compared with control.

*

P<0.005 was considered significant.